The Cannabis Cancer Connection
Project CBD
OCTOBER 26, 2023
They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM). See chapter: Cannabinoids, Terpenes & Flavonoids ). GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising.
Let's personalize your content